Evaluating Co-Expression of EZH2 and MYC in Mantle Cell Lymphoma

被引：0
|
作者：
Patel, Sanjay
Eikhoff, Jens
Shaw, Gene
Kahl, Brad
Yang, David
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1478
引用
收藏
页码：371A / 371A
页数：1
相关论文
共 50 条
  • [41] Enhancer of Zeste Homolog 2 (EZH2) Is Widely Expressed in T-Cell Neoplasms and Correlates with MYC Expression in Most Subtypes
    Shi, M.
    Shahsafaei, A.
    Yu, H.
    Dorfman, D. M.
    LABORATORY INVESTIGATION, 2014, 94 : 378A - 379A
  • [42] Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
    Lee, Hye Won
    Choe, Misun
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 735 - 741
  • [43] Efficacy of Combined Epigenetic Targeting of Histone Methyltransferase EZH2 and Histone deacetylases Against Human Mantle Cell Lymphoma Cells.
    Fiskus, Warren
    Rao, Rekha
    Balusu, Ramesh
    Tao, Jianguo
    Sotomayor, Eduardo M.
    Atadja, Peter
    Bhalla, Kapil N.
    BLOOD, 2010, 116 (21) : 1032 - 1032
  • [44] EZH2 inhibition for epithelioid sarcoma and follicular lymphoma
    Groisberg, Roman
    Subbiah, Vivek
    LANCET ONCOLOGY, 2020, 21 (11): : 1388 - 1390
  • [45] Up-regulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated p-ERK Co-expression and PRC2 Correlation Contributing to Tumor Aggressiveness in Adult T cell Leukemia/Lymphoma (ATLL)
    Chai, Jiani
    Choudhuri, Jui
    Shen, Wa
    Wang, Yanhua
    Tian, Xuejun
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1110 - S1111
  • [46] Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas
    Tian, Xuejun
    Pelton, Ashley
    Shahsafaei, Ali
    Dorfman, David M.
    MODERN PATHOLOGY, 2016, 29 (09) : 1050 - 1057
  • [47] Developmental and tissue specific expression of EZH2
    Chen, Yangchao
    Kung, Hsiang-fu
    FASEB JOURNAL, 2008, 22
  • [48] EZH2 Expression in Intestinal Neuroendocrine Tumors
    Faviana, Pinuccia
    Marconcini, Riccardo
    Ricci, Sergio
    Galli, Luca
    Lippolis, Piero
    Farci, Fabiola
    Castagna, Maura
    Boldrini, Laura
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (09) : 689 - 693
  • [49] CONCOMITANT INHIBITION OF EZH1 AND EZH2 IMPAIRS GROWTH OF C-MYC DRIVEN B CELL LYMPHOMAS
    Petrocelli, V.
    Varano, G.
    Carrisi, C.
    Rahmat, M.
    Zanardi, F.
    Jin, J.
    Casola, S.
    HAEMATOLOGICA, 2014, 99 : 133 - 134
  • [50] A novel selective EZH2 inhibitor exhibits anti-tumor activity in lymphoma with EZH2 activating mutations
    Creasy, Caretha L.
    McCabe, Michael T.
    Korenchuk, Susan
    Diaz, Elsie
    Ott, Heidi
    Thompson, Christine S.
    Ganji, Gopi
    Gorman, Shelby A.
    LaFrance, Louis V.
    Brandt, Martin
    McHugh, Charles
    Verma, Sharad K.
    Tummino, Peter J.
    CANCER RESEARCH, 2012, 72
12345